Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Status:
Withdrawn
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine if ziprasidone is superior to standard therapies in the
emergency department treatment of the acutely agitated patient. The primary outcome will be
the length of time taken until the patient is ready to be evaluated by the psychiatric
service, or until a disposition is made.